Judy Lowe
Family · Murfreesboro, TNNPI 1376566810
Payments from drug & device makers
Across 43 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$444
- Novartis$73
- AstraZeneca$57
- Axsome Therapeutics, Inc.$53
- Merck$42
- Esperion Therapeutics, Inc.$31
- plus $148 from 7 others
What the payments were for
- Food & beverage$847100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $444 |
| Novartis | 4 | $73 |
| AstraZeneca(2 entities) | 4 | $57 |
| Axsome Therapeutics, Inc. | 1 | $53 |
| Merck | 3 | $42 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Amgen | 2 | $28 |
| Amarin Pharma, Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $14 |
| GSK | 1 | $13 |
| Eisai Inc. | 1 | $13 |
How this compares
$847 in reported general payments places this provider in the 60th percentile of 6,706 family providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 22 | $22,570 |
| GemtesaVibegron | 13 | $8,763 |
| MyrbetriqMirabegron | 12 | $8,195 |
| Estradiol | 16 | $1,415 |
| Atorvastatin Calcium | 79 | $762 |
| Valsartan | 15 | $696 |
| Metoprolol Succinate | 29 | $679 |
| Rosuvastatin Calcium | 53 | $654 |
| Levothyroxine Sodium | 42 | $489 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 15 | $484 |
| Pantoprazole Sodium | 29 | $431 |
| Famotidine | 36 | $400 |
| Losartan Potassium | 28 | $388 |
| Montelukast Sodium | 30 | $366 |
| Duloxetine Hcl | 24 | $351 |
Paid to pharmacies, not to this prescriber.
Other family in Murfreesboro
- Cynthia MillerMurfreesboro$384K
- Melanie McGheeMurfreesboro$48K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.